- Publication status:
- Publisher copy:
- Copyright date:
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
If you are the owner of this record, you can report an update to it here: Report update to this record